TRIM72

Chr 16

tripartite motif containing 72

Also known as: MG53

The protein functions as a muscle-specific E3 ubiquitin ligase that plays a central role in cell membrane repair by nucleating assembly of repair machinery at injury sites and regulating membrane budding and exocytosis. Mutations in this gene cause limb-girdle muscular dystrophy, which is inherited in an autosomal recessive pattern. The gene shows very low constraint to loss-of-function variants (pLI near 0), suggesting haploinsufficiency is well-tolerated.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.05
Clinical SummaryTRIM72
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 108 VUS of 129 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.05LOEUF
pLI 0.000
Z-score 1.42
OE 0.60 (0.361.05)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.45Z-score
OE missense 0.75 (0.670.84)
198 obs / 264.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.60 (0.361.05)
00.351.4
Missense OE0.75 (0.670.84)
00.61.4
Synonymous OE0.78
01.21.6
LoF obs/exp: 9 / 14.9Missense obs/exp: 198 / 264.5Syn Z: 1.88
DN
0.80top 25%
GOF
0.84top 5%
LOF
0.1399th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

129 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic1
VUS108
Likely Benign6
Benign2
9
Pathogenic
1
Likely Pathogenic
108
VUS
6
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
9
0
9
Likely Pathogenic
0
0
1
0
1
VUS
0
101
7
0
108
Likely Benign
0
5
0
1
6
Benign
0
1
0
1
2
Total0107172126

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRIM72 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →